News & Events

Stay up-to-date with our news and our latest developments


Meet GenDx at EFI 2026

Published on March 19, 2026

We are happy to announce that GenDx will be present at EFI 2026 in Edinburgh with a platinum sponsorship! The […]

Read more

GenDx and Treos Bio Announce Partnership to develop HLA-based Companion Diagnostic for PolyPEPI1018 Cancer Immunotherapy

Published on March 17, 2026

PRESS RELEASE Utrecht and London, 17 March 2026 GenDx, a Eurobio Scientific Company, based in the Netherlands, specialized in molecular […]

Read more

Navigating Grey Zones & Growing Pains: Developments in the Regulatory CDx Space

Published on March 16, 2026

๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ณ๐—ผ๐—ฟ ๐—ผ๐˜‚๐—ฟ ๐—ป๐—ฒ๐˜„ ๐˜„๐—ฒ๐—ฏ๐—ถ๐—ป๐—ฎ๐—ฟ! During this webinar,ย Kirsten van Garsse (QbD Group)ย andย Jules Petitย will discuss key elements of our joint panel […]

Read more

Meet GenDx at the 16th Annual CB & CDx summit Europe in London!

Published on March 12, 2026

We are thrilled to announce that the GenDx Companion Diagnostics team is heading to London for the 16th Annual CB […]

Read more

HLA nomenclature: Understanding the structure of HLA allele names

Published on March 5, 2026

In the world of transplantation and clinical immunology, HLA (Human Leukocyte Antigen) typing is the ultimate “barcode” of human identity. […]

Read more

Supporting Precision Medicine: Our Companion Diagnostics (CDx) services

Published on February 19, 2026

We are excited to share that GenDx updated its website to better showcase our comprehensive Companion Diagnostics (CDx) services. Our […]

Read more